https://painkills2.wordpress.com/2015/03/05/it-appears-that-express-scripts-really-sucks/
Express Scripts ($ESRX) will put its money behind a new value-based reimbursement model next year, using comparative data and indication-specific pricing to favor “clinically superior” meds. The pharmacy benefits manager will roll out the approach in cancer first, with anti-inflammatory meds close behind…
If Erbitux’s price were linked to results, it would run $10,319 in premetastatic head and neck cancer, where it delivers the best results, Bach suggests. For head and neck cancer that has recurred or spread–an indication where it’s less beneficial–the price would be $471 per month, Bach suggests…
Roche CEO Severin Schwan thinks indication-based pricing is a reasonable approach, Bloomberg reports. “The value of a cancer drug can be very different for different indications,” Schwan told the news service this week. “It makes a lot of sense to align the price with different indications.”
What’s the insurance industry up to now?
All Things Chronic 
Express scripts is the absolute worst manager of mail order scripts and cost individuals and the government more than anyone else. I have tons of data on this also. I have terrible insomnia and hopefully will be able to get the info I promised to you soon
LikeLiked by 1 person
I don’t remember you promising me anything, but since I also have insomnia, maybe I just forgot. 🙂 Anyway, I don’t use Express Scripts, but I know it’s the largest pharmacy benefit manager and the other ones seem to follow its lead.
LikeLiked by 1 person
Yes, Express Scripts and CVS control the pharmacy empire. On my last blog about the insurance numbers and how the insurance companies are loseing money with the ACA, I promised to get you some numbers. I simply haven’t posted them for you yet. That’s what I was talking about.
I also have insomnia. I rarely make it to bed before 7:30 a.m. and then for a couple of hours. All I can say about insomnia right now is that it sucks.
LikeLiked by 1 person